{"entity":{"type":"insider","cik":"0001760510","url":"/insider/0001760510","json_url":"/insider/0001760510.json","name":"Dagnon Terry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-02-17","last":"2023-04-21","span_basis":"filed_date"},"name_variants":[{"name":"Dagnon Terry","source":"filing","n_filings":6,"first_seen":"2021-02-17","last_seen":"2023-04-21"}],"transactions":[{"id":8438039,"accession":"0001209191-23-025294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025294","line_url":"/filing/0001209191-23-025294#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":520000.0,"shares_display":"520,000","price_per_share":1.135,"price_display":"1.14","price_state":"stated","total_value":590200.0,"total_display":"590,200.00","total_whole":"590,200","shares_owned_after":653058.0,"shares_owned_after_display":"653,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-21","scope":"insider"},{"id":6496980,"accession":"0001209191-22-038989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038989","line_url":"/filing/0001209191-22-038989#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","total_whole":"10,500","shares_owned_after":1173058.0,"shares_owned_after_display":"1,173,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":5385337,"accession":"0001209191-21-068135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-068135","line_url":"/filing/0001209191-21-068135#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25201.0,"shares_display":"25,201","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":34777.38,"total_display":"34,777.38","total_whole":"34,777","shares_owned_after":1163058.0,"shares_owned_after_display":"1,163,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-06","scope":"insider"},{"id":4795112,"accession":"0001209191-21-067838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067838","line_url":"/filing/0001209191-21-067838#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":14200.0,"total_display":"14,200.00","total_whole":"14,200","shares_owned_after":1137857.0,"shares_owned_after_display":"1,137,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-03","scope":"insider"},{"id":4554728,"accession":"0001209191-21-014542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-014542","line_url":"/filing/0001209191-21-014542#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15900.0,"shares_display":"15,900","price_per_share":2.088,"price_display":"2.09","price_state":"stated","total_value":33199.2,"total_display":"33,199.20","total_whole":"33,199","shares_owned_after":1127857.0,"shares_owned_after_display":"1,127,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-25","scope":"insider"},{"id":5286108,"accession":"0001209191-21-011611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011611","line_url":"/filing/0001209191-21-011611#line-1","is_derivative":false,"issuer_cik":"0001649989","issuer_name":"Outlook Therapeutics, Inc.","issuer_ticker":"OTLK","issuer_name_source":null,"issuer_url":"/issuer/0001649989","owner_cik":"0001760510","owner_name":"Dagnon Terry","owner_display_name":"Dagnon Terry","owner_url":"/insider/0001760510","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63700.0,"shares_display":"63,700","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":162435.0,"total_display":"162,435.00","total_whole":"162,435","shares_owned_after":1143757.0,"shares_owned_after_display":"1,143,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-12","filed_date":"2021-02-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649989","name":"Outlook Therapeutics, Inc.","url":"/issuer/0001649989","role":"Officer (Chief Operations Officer)","n_filings":6,"first_seen":"2021-02-17","last_seen":"2023-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760510","retrieved_at":"2026-08-27T02:55:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}